NCT03310970View on ClinicalTrials.gov

Pharmacokinetics of Lidocaine in Healthy Adults

PHASE4CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

March 14, 2018

Primary Completion Date

October 9, 2019

Study Completion Date

October 9, 2019

Conditions
Healthy
Interventions
DRUG

Lidocaine 5% patch

Each subject will wear three generic Lidocaine 5% topical patches for 12 hours.

DRUG

Lidocaine hydrochloride

Each subject will receive a dose of 0.5 mg/kg intravenously over a period of 5 minutes.

DRUG

Lidoderm 5% patch

Each subject will wear three Lidoderm® topical patches for 12 hours.

Trial Locations (1)

52242

University of Iowa, Iowa City

All Listed Sponsors
collaborator

Long Island University

OTHER

lead

Nicole K Brogden

OTHER

NCT03310970 - Pharmacokinetics of Lidocaine in Healthy Adults | Biotech Hunter | Biotech Hunter